Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Stratification Using Positron Emission Tomography (PET) in Hypertrophic Cardiomyopathy (HCM)

NCT03278457 is registered in ClinicalTrials.gov with Region Gävleborg as lead sponsor.

NCT NCT03278457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03278457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Stratification Using Positron Emission Tomography (PET) in Hypertrophic Cardiomyopathy (HCM)
Lead sponsor
Region Gävleborg
Phase
Observational
Overall status
Unknown status
Start date
May 3, 2017
Completion date
June 3, 2018
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy